Incyte Corp (NAS:INCY)
$ 121.47 -1.82 (-1.48%) Market Cap: 24.62 Bil Enterprise Value: 20.12 Bil PE Ratio: 15.47 PB Ratio: 3.85 GF Score: 87/100

Incyte Corp at Cantor Global Healthcare Conference Transcript

Sep 10, 2026 / 01:45PM GMT
Release Date Price: $123.28 (-2.17%)
Eric Schmidt
Cantor Fitzgerald LP - Analyst

Welcome to the Cantor conference. My name is Eric Schmidt, and it's my pleasure to moderate the next session with my colleague, Imogen Mansfield. And delighted to have with us the Incyte team, fresh off a big year and looking forward to a very eventful fall as well. We've got the company's Chief Executive Officer, Bill Meury, as well as the company's President, Head of R&D, Pablo Cagnoni. Pablo, Bill, thank you for being here.

William Meury
Incyte Corp - Chief Executive Officer, Director

Good to be here.

Eric Schmidt
Cantor Fitzgerald LP - Analyst

Bill, it's been just about a year since you took the helm. So give us a lay of the land and what's worked well over that intervening period since we last saw you.

William Meury
Incyte Corp - Chief Executive Officer, Director

Yeah, look, I joined the company just about 14-, 15 months ago. One of the things I observed from the outside looking in is that the pipeline when I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot